|
|
||||||||
Harvard Medical School and Peter Bent Brigham Hospital, Boston
Massachusetts Institute of Technology, Cambridge, Massachusetts
Correspondence: For reprints contact: Alun G. Jones, PhD, Harvard Medical School, 50 Binney St., Boston, MA 02115.
ABSTRACT
We have studied the effectiveness of various reducing agents in the production of the well-characterized complex [99TcO(SCH2CH2S)2] from pertechnetate and ethanedithiol in aqueous solution. The reductants tested included sodium dithionite, hypophosphorous acid, formamidine sulfinic acid, dithiothreitol, hydrazine, and hydroxylamine. Of these, only sodium dithionite in the pH range 11-13 was found to give quantitative yields of the required technetium complex.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |